Cargando…
Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing
A sufficiently large tissue sample is required to perform next-generation sequencing (NGS) with a high success rate, but the majority of patients with advanced non-small-cell lung cancer (NSCLC) are diagnosed with small biopsy specimens. Biopsy samples were collected from 184 patients with bronchosc...
Autores principales: | Murakami, Shuji, Yokose, Tomoyuki, Nemoto, Daiji, Suzuki, Masaki, Usui, Ryou, Nakahara, Yoshiro, Kondo, Tetsuro, Kato, Terufumi, Saito, Haruhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996548/ https://www.ncbi.nlm.nih.gov/pubmed/33668993 http://dx.doi.org/10.3390/diagnostics11030391 |
Ejemplares similares
-
Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020) -
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting
EGFR
mutations
por: Murakami, Shuji, et al.
Publicado: (2022) -
Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples
por: Nemoto, Daiji, et al.
Publicado: (2020) -
Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer
por: Moda, Mitsuhiro, et al.
Publicado: (2020) -
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next‐generation sequencing technique
por: Manabe, Saki, et al.
Publicado: (2020)